These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 28784691)
1. DNA of Erythroid Origin Is Present in Human Plasma and Informs the Types of Anemia. Lam WKJ; Gai W; Sun K; Wong RSM; Chan RWY; Jiang P; Chan NPH; Hui WWI; Chan AWH; Szeto CC; Ng SC; Law MF; Chan KCA; Chiu RWK; Lo YMD Clin Chem; 2017 Oct; 63(10):1614-1623. PubMed ID: 28784691 [TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of murine terminal erythroid differentiation in vivo: novel method to study normal and disordered erythropoiesis. Liu J; Zhang J; Ginzburg Y; Li H; Xue F; De Franceschi L; Chasis JA; Mohandas N; An X Blood; 2013 Feb; 121(8):e43-9. PubMed ID: 23287863 [TBL] [Abstract][Full Text] [Related]
3. Enhancing mitochondrial function in vivo rescues MDS-like anemia induced by pRb deficiency. Sen T; Jain M; Gram M; Mattebo A; Soneji S; Walkley CR; Singbrant S Exp Hematol; 2020 Aug; 88():28-41. PubMed ID: 32629063 [TBL] [Abstract][Full Text] [Related]
4. Role of Plasma Gelsolin Protein in the Final Stage of Erythropoiesis and in Correction of Erythroid Dysplasia In Vitro. Han SY; Lee EM; Kim S; Kwon AM; Baek EJ Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992584 [TBL] [Abstract][Full Text] [Related]
5. Ratio of bone marrow reticulocytes to peripheral corrected reticulocytes for evaluating ineffective erythropoiesis. Choi JW Ann Clin Lab Sci; 2006; 36(4):439-41. PubMed ID: 17127730 [No Abstract] [Full Text] [Related]
6. Homeostatic erythropoiesis by the transcription factor IRF2 through attenuation of type I interferon signaling. Mizutani T; Tsuji K; Ebihara Y; Taki S; Ohba Y; Taniguchi T; Honda K Exp Hematol; 2008 Mar; 36(3):255-64. PubMed ID: 18207304 [TBL] [Abstract][Full Text] [Related]
7. FOXO3-mTOR metabolic cooperation in the regulation of erythroid cell maturation and homeostasis. Zhang X; Campreciós G; Rimmelé P; Liang R; Yalcin S; Mungamuri SK; Barminko J; D'Escamard V; Baron MH; Brugnara C; Papatsenko D; Rivella S; Ghaffari S Am J Hematol; 2014 Oct; 89(10):954-63. PubMed ID: 24966026 [TBL] [Abstract][Full Text] [Related]
8. [Hematological characteristics of hypoplastic MDS patients with chromosomal abnormalities, who had been followed for aplastic anemia with normal karyotypes]. Tamai Y; Takami H; Nakahata R; Nakui Y; Suzuki Y; Akagi T; Kariya K; Tsushima K; Munakata A; Kawamura S Rinsho Ketsueki; 1997 Dec; 38(12):1243-8. PubMed ID: 9455142 [TBL] [Abstract][Full Text] [Related]
10. Serum erythropoietin and erythropoiesis in patients with myelodysplastic syndromes. Bowen DT; Jacobs A; Cotes PM; Lewis TC Eur J Haematol; 1990 Jan; 44(1):30-2. PubMed ID: 2307217 [TBL] [Abstract][Full Text] [Related]
11. High serum iron in human parvovirus-induced aplastic crisis in iron deficiency anemia. Kojima S; Matsuyama K; Ishii E Acta Haematol; 1988; 80(3):171-2. PubMed ID: 2848388 [TBL] [Abstract][Full Text] [Related]
12. Iron deficiency anemia, beta-thalassemia minor, and anemia of chronic disease: a morphologic reappraisal. Harrington AM; Ward PC; Kroft SH Am J Clin Pathol; 2008 Mar; 129(3):466-71. PubMed ID: 18285271 [TBL] [Abstract][Full Text] [Related]
13. Hematopoietic deletion of transferrin receptor 2 in mice leads to a block in erythroid differentiation during iron-deficient anemia. Rishi G; Secondes ES; Wallace DF; Subramaniam VN Am J Hematol; 2016 Aug; 91(8):812-8. PubMed ID: 27169626 [TBL] [Abstract][Full Text] [Related]
14. A plasma microRNA signature as a biomarker for acquired aplastic anemia. Hosokawa K; Kajigaya S; Feng X; Desierto MJ; Fernandez Ibanez MD; Rios O; Weinstein B; Scheinberg P; Townsley DM; Young NS Haematologica; 2017 Jan; 102(1):69-78. PubMed ID: 27658437 [TBL] [Abstract][Full Text] [Related]
15. Pathophysiological classification of acquired bone marrow failure based on quantitative assessment of erythroid function. Cazzola M; Bergamaschi G; Huebers HA; Finch CA Eur J Haematol; 1987 May; 38(5):426-32. PubMed ID: 3653364 [TBL] [Abstract][Full Text] [Related]
16. Marked erythropoietin-induced dysplastic erythropoiesis in a patient with myelodysplastic syndrome. Narukawa K; Masuda A; Takahashi T Int J Hematol; 2021 Jun; 113(6):775-776. PubMed ID: 33864622 [No Abstract] [Full Text] [Related]
17. [A study of hypoplastic myelodysplastic syndrome]. Sato Y; Mituhashi S; Otani K; Kamoshita M; Hasegawa Y; Ninomiya H; Nagasawa T; Abe T Rinsho Ketsueki; 1993 Nov; 34(11):1431-7. PubMed ID: 8254904 [TBL] [Abstract][Full Text] [Related]
18. Impaired formation of erythroblastic islands is associated with erythroid failure and poor prognosis in a significant proportion of patients with myelodysplastic syndromes. Buesche G; Teoman H; Giagounidis A; Göhring G; Schlegelberger B; Ganser A; Aul C; Kreipe HH Haematologica; 2016 May; 101(5):e177-81. PubMed ID: 26944473 [No Abstract] [Full Text] [Related]
19. In vitro studies of erythropoietin-dependent regulation of erythropoiesis in myelodysplastic syndromes. Merchav S; Nielsen OJ; Rosenbaum H; Sharon R; Brenner B; Tatarsky I; Scigalla P; Wieczorek L Leukemia; 1990 Nov; 4(11):771-4. PubMed ID: 2232891 [TBL] [Abstract][Full Text] [Related]